Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2008

01-12-2008 | Case Report

Membranous nephropathy (bubbling appearance and spike formation) without immunoglobulin deposition in a patient with systemic lupus erythematosus

Authors: Naoto Miura, Yuki Mori, Masabumi Yoshino, Norihiro Suga, Wataru Kitagawa, Harutaka Yamada, Kazuhiro Nishikawa, Hirokazu Imai

Published in: Clinical and Experimental Nephrology | Issue 6/2008

Login to get access

Abstract

A 53-year-old Japanese man with systemic lupus erythematosus developed proteinuria and hematuria after a urinary stone episode. A light microscopic study of a kidney biopsy specimen demonstrated a bubbling appearance and spike formation of the basement membrane. Immunofluorescent studies revealed that there were no significant depositions of immunoglobulins, such as IgG (−), IgA (−), IgM (±), κ light chain (±), λ light chain (±), or C3 (−) in the glomerular capillary wall, though C1q was present as one-plus positive staining in mesangial areas. Electron microscopic studies showed that the thickness of the basement membrane varied from thin to thick without electron dense deposits, and that the cellular components of the podocyte were irregularly present in the basement membrane. Urinary protein decreased after the usage of prednisolone and mizoribine; however, proteinuria aggravated after an episode of urinary stone during the same treatment.
Literature
1.
go back to reference Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science. 1998;279:1052–4.CrossRefPubMed Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science. 1998;279:1052–4.CrossRefPubMed
3.
go back to reference Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997;51:270–6.CrossRefPubMed Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997;51:270–6.CrossRefPubMed
4.
go back to reference Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published erratum appears in J Am Soc Nephrol 2004; 15:835–6]. J Am Soc Nephrol. 2004;15:241–50.CrossRefPubMed Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published erratum appears in J Am Soc Nephrol 2004; 15:835–6]. J Am Soc Nephrol. 2004;15:241–50.CrossRefPubMed
5.
go back to reference Schwartz MM, Kawala K, Roberts JL, Mumes C, Lewis EJ. Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus. Am J Nephrol. 1984;4:301–11.CrossRefPubMed Schwartz MM, Kawala K, Roberts JL, Mumes C, Lewis EJ. Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus. Am J Nephrol. 1984;4:301–11.CrossRefPubMed
6.
go back to reference LeBleu VS, MacDonald B, Kalluri R. Structure and function of basement membranes. Exp Biol Med. 2007;232:1121–9.CrossRef LeBleu VS, MacDonald B, Kalluri R. Structure and function of basement membranes. Exp Biol Med. 2007;232:1121–9.CrossRef
7.
go back to reference Marin MP, Esteban-Pretel G, Alonso R, Sado Y, Barber T, Renau-Piqueras J, et al. Vitamin A deficiency alters the structure and collagen IV composition of rat renal basement membranes. J Nutr. 2005;135:695–701.CrossRefPubMed Marin MP, Esteban-Pretel G, Alonso R, Sado Y, Barber T, Renau-Piqueras J, et al. Vitamin A deficiency alters the structure and collagen IV composition of rat renal basement membranes. J Nutr. 2005;135:695–701.CrossRefPubMed
Metadata
Title
Membranous nephropathy (bubbling appearance and spike formation) without immunoglobulin deposition in a patient with systemic lupus erythematosus
Authors
Naoto Miura
Yuki Mori
Masabumi Yoshino
Norihiro Suga
Wataru Kitagawa
Harutaka Yamada
Kazuhiro Nishikawa
Hirokazu Imai
Publication date
01-12-2008
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2008
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-008-0096-8

Other articles of this Issue 6/2008

Clinical and Experimental Nephrology 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.